BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 28, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cinryze regulatory update

ViroPharma said it plans to submit a response next quarter to an October 2010 complete response letter from FDA about the expansion of industrial scale manufacturing for Cinryze. In the letter, ViroPharma said FDA requested responses to quality observations during a pre-approval inspection,...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >